University of Chicago at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

University of Chicago takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on plasma p-tau217 in people with cardiovascular disease and what else moves the test, including age, APOE status, kidney function, glucose and prior stroke.

Organization	CTAD 2026 Attendance
University of Chicago Chicago, Illinois
	Poster Wed Nov 18 7:15am–5:30pm Age, APOE Status, Renal Function, Glycemia, and Prior Ischemic Stroke Associate With Baseline Plasma p-tau217 in BROADWAY. (P217) Blood and CSF biomarkers Poster Wed Nov 18 7:15am–5:30pm Plasma p-tau217 above and below validated Alzheimer cutoffs in cardiovascular disease: between-range versus within-range determinants in BROADWAY. (P219) Blood and CSF biomarkers

Organization

CTAD 2026 Attendance

University of Chicago

Chicago, Illinois

Poster

Wed Nov 18
7:15am–5:30pm

Age, APOE Status, Renal Function, Glycemia, and Prior Ischemic Stroke Associate With Baseline Plasma p-tau217 in BROADWAY. (P217)

Blood and CSF biomarkers

Poster

Wed Nov 18
7:15am–5:30pm

Plasma p-tau217 above and below validated Alzheimer cutoffs in cardiovascular disease: between-range versus within-range determinants in BROADWAY. (P219)

Blood and CSF biomarkers

Instantly find 20 buyers from University of Chicago

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction